Chinese Journal of Chromatography ›› 2020, Vol. 38 ›› Issue (5): 538-546.DOI: 10.3724/SP.J.1123.2019.09017
Previous Articles Next Articles
CHEN Xinglian1, LIN Tao1, LIU Xingyong1, MEI Wenquan1, WANG Li1, GENG Huichun1, CHENG Long2, WANG Luxiang1,*()
Received:
2019-10-08
Online:
2020-05-08
Published:
2020-12-10
Contact:
WANG Luxiang
Supported by:
CHEN Xinglian, LIN Tao, LIU Xingyong, MEI Wenquan, WANG Li, GENG Huichun, CHENG Long, WANG Luxiang. Rapid determination of multiple prohibited and restricted veterinary drug residues in fish and shrimp by ultra high performance liquid chromatography-tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2020, 38(5): 538-546.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2019.09017
Compound | Chinese name | Retention time/min | Precursor ion (m/z) | Product ions (m/z) | DP/V | CEs/V | IS |
DP: declustering potential; CE: collision energy; * quantitative ion. | |||||||
Sulfadiazine (SD) | 磺胺嘧啶 | 1.9 | 251 | 156*/185 | 55 | 23/27 | SDX-D3 |
Sulfathiazole (ST) | 磺胺噻唑 | 2.1 | 285 | 156*/108 | 70 | 19/30 | SDX-D3 |
Norfloxacin (NOR) | 诺氟沙星 | 2.2 | 320 | 276*/233 | 80 | 26/35 | NOR-D5 |
Fleroxacin (FLE) | 弗罗沙星 | 2.2 | 370 | 326*/269 | 80 | 26/37 | NOR-D5 |
Ofloxacin (OFL) | 氧氟沙星 | 2.2 | 362 | 318*/261 | 60 | 25/35 | NOR-D5 |
Ciprofloxacin (CIP) | 环丙沙星 | 2.3 | 332 | 288*/245 | 80 | 25/33 | CIP-D8 |
5-Morpholine-methyl-3-amino- | 5-甲基吗啉-3氨基- | 2.3 | 335 | 291*/262 | 66 | 18/24 | D5-AMOZ |
2-oxazolidinone (AMOZ) | |||||||
Sulfamerazine (SMR) | 磺胺甲基嘧啶 | 2.3 | 265 | 156*/172 | 50 | 25/24 | SDX-D3 |
Pefloxacin (PEF) | 培氟沙星 | 2.3 | 334 | 316*/290 | 118 | 27/24 | NOR-D5 |
Lomefloxacin (LOM) | 洛美沙星 | 2.4 | 352 | 308*/265 | 60 | 27/31 | CIP-D8 |
Thiamphenicol (TAP) | 甲砜霉素 | 2.4 | 354 | 185*/290 | -75 | -28/-16 | CAP-D5 |
Enrofloxacin (ENR) | 恩诺沙星 | 2.5 | 360 | 316*/245 | 80 | 28/36 | ENR-D5 |
Sulfamethazine (SMT) | 磺胺二甲基嘧啶 | 2.6 | 279 | 156*/204 | 55 | 22/20 | SDX-D3 |
Sulfamethizol (SMTZ) | 磺胺甲噻二唑 | 2.6 | 271 | 108*/92 | 60 | 33/36 | SDX-D3 |
Florfenicol (FF) | 氟甲砜霉素 | 2.7 | 356 | 336*/185 | -70 | -14/-27 | CAP-D5 |
Sulfamonomethoxine (SMM) | 磺胺间甲氧嘧啶 | 3.0 | 281 | 156*/215 | 65 | 25/25 | SDX-D3 |
Sulfachloropyridazine (SCP) | 磺胺氯哒嗪 | 3.1 | 285 | 156*/108 | 50 | 23/35 | SDX-D3 |
Chloramphenicol (CAP) | 氯霉素 | 3.1 | 321 | 152*/257 | -70 | -24/-17 | CAP-D5 |
Sulfadoxine(SDX) | 磺胺邻二甲氧嘧啶 | 3.3 | 311 | 156*/108 | 70 | 31/35 | SDX-D3 |
Semicarbazide (SEM) | 氨基脲 | 3.3 | 209 | 192*/166 | 51 | 15/17 | 13C15N2-SEM |
Sulfamethoxazole (SMZ) | 磺胺甲基异 | 3.4 | 254 | 156*/147 | 50 | 23/22 | SDX-D3 |
1-Aminohydantoin (AHD) | 1-氨基-2-内酰脲 | 3.4 | 249 | 134*/104 | 60 | 18/33 | 13C3-AHD |
Sulfisoxazole (SIZ) | 磺胺二甲异 | 3.5 | 268 | 156*/113 | 45 | 20/23 | SDM-D6 |
3-Amino-2-oxazolidinone (AOZ) | 3-氨基- | 3.8 | 236 | 134*/104 | 61 | 18/33 | D4-AOZ |
Sulfaquinoxalin (SQX) | 磺胺喹 | 3.9 | 301 | 156*/108 | 55 | 24/37 | SDM-D6 |
Sulfadimethoxine (SDM) | 磺胺间二甲氧嘧啶 | 3.9 | 311 | 156*/108 | 70 | 31/35 | SDM-D6 |
Malachite green (MG) | 孔雀石绿 | 4.9 | 329 | 313*/208 | 101 | 53/46 | MG-D5 |
Leucomalachite green (LMG) | 隐色孔雀石绿 | 6.8 | 331 | 239*/315 | 76 | 45/32 | LMG-D6 |
Norfloxacin-D5(NOR-D5) | 诺氟沙星-D5 | 2.2 | 325 | 307 | 80 | 26 | |
Ciprofloxacin-D8 (CIP-D8) | 环丙沙星-D8 | 2.3 | 340 | 322 | 90 | 30 | |
D5-5-Morpholine-methyl-3-amino- | 5-甲基吗啉-3氨基- | 2.3 | 340 | 296 | 70 | 18 | |
2-oxazolidinone (D5-AMOZ) | |||||||
Enrofloxacin-D5(ENR-D5) | 恩诺沙星-D5 | 2.4 | 365 | 321 | 90 | 30 | |
Sulfadoxine-D3(SDX-D3) | 磺胺邻二甲氧嘧啶-D3 | 3.2 | 314 | 156 | 70 | 31 | |
13C15N2-Semicarbazide (13C15N2-SEM) | 13C15N2-氨基脲 | 3.3 | 212 | 168 | 57 | 15 | |
Chloramp henicol-D5 (CAP-D5) | 氯霉素-D5 | 3.3 | 326 | 157 | -75 | -22 | |
13C3-1-Aminohydantoin (13C3-AHD) | 13C3-1-氨基-2-内酰脲 | 3.4 | 252 | 134 | 61 | 18 | |
D4-3-Amino-2-oxazolidinone (D4-AOZ) | D4-3-氨基- | 3.8 | 240 | 134 | 68 | 20 | |
Sulfadimethoxine-D6(SDM-D6) | 磺胺间二甲氧嘧啶-D6 | 3.9 | 317 | 156 | 70 | 31 | |
Malachite green-D5 (MG-D5) | 孔雀石绿-D5 | 4.9 | 334 | 318 | 66 | 54 | |
Leucomalachite green-D6 (LMG-D6) | 隐色孔雀石绿-D6 | 6.7 | 337 | 321 | 66 | 32 |
Table 1 MS parameters for the 28 veterinary drugs and 12 isotope internal standards
Compound | Chinese name | Retention time/min | Precursor ion (m/z) | Product ions (m/z) | DP/V | CEs/V | IS |
DP: declustering potential; CE: collision energy; * quantitative ion. | |||||||
Sulfadiazine (SD) | 磺胺嘧啶 | 1.9 | 251 | 156*/185 | 55 | 23/27 | SDX-D3 |
Sulfathiazole (ST) | 磺胺噻唑 | 2.1 | 285 | 156*/108 | 70 | 19/30 | SDX-D3 |
Norfloxacin (NOR) | 诺氟沙星 | 2.2 | 320 | 276*/233 | 80 | 26/35 | NOR-D5 |
Fleroxacin (FLE) | 弗罗沙星 | 2.2 | 370 | 326*/269 | 80 | 26/37 | NOR-D5 |
Ofloxacin (OFL) | 氧氟沙星 | 2.2 | 362 | 318*/261 | 60 | 25/35 | NOR-D5 |
Ciprofloxacin (CIP) | 环丙沙星 | 2.3 | 332 | 288*/245 | 80 | 25/33 | CIP-D8 |
5-Morpholine-methyl-3-amino- | 5-甲基吗啉-3氨基- | 2.3 | 335 | 291*/262 | 66 | 18/24 | D5-AMOZ |
2-oxazolidinone (AMOZ) | |||||||
Sulfamerazine (SMR) | 磺胺甲基嘧啶 | 2.3 | 265 | 156*/172 | 50 | 25/24 | SDX-D3 |
Pefloxacin (PEF) | 培氟沙星 | 2.3 | 334 | 316*/290 | 118 | 27/24 | NOR-D5 |
Lomefloxacin (LOM) | 洛美沙星 | 2.4 | 352 | 308*/265 | 60 | 27/31 | CIP-D8 |
Thiamphenicol (TAP) | 甲砜霉素 | 2.4 | 354 | 185*/290 | -75 | -28/-16 | CAP-D5 |
Enrofloxacin (ENR) | 恩诺沙星 | 2.5 | 360 | 316*/245 | 80 | 28/36 | ENR-D5 |
Sulfamethazine (SMT) | 磺胺二甲基嘧啶 | 2.6 | 279 | 156*/204 | 55 | 22/20 | SDX-D3 |
Sulfamethizol (SMTZ) | 磺胺甲噻二唑 | 2.6 | 271 | 108*/92 | 60 | 33/36 | SDX-D3 |
Florfenicol (FF) | 氟甲砜霉素 | 2.7 | 356 | 336*/185 | -70 | -14/-27 | CAP-D5 |
Sulfamonomethoxine (SMM) | 磺胺间甲氧嘧啶 | 3.0 | 281 | 156*/215 | 65 | 25/25 | SDX-D3 |
Sulfachloropyridazine (SCP) | 磺胺氯哒嗪 | 3.1 | 285 | 156*/108 | 50 | 23/35 | SDX-D3 |
Chloramphenicol (CAP) | 氯霉素 | 3.1 | 321 | 152*/257 | -70 | -24/-17 | CAP-D5 |
Sulfadoxine(SDX) | 磺胺邻二甲氧嘧啶 | 3.3 | 311 | 156*/108 | 70 | 31/35 | SDX-D3 |
Semicarbazide (SEM) | 氨基脲 | 3.3 | 209 | 192*/166 | 51 | 15/17 | 13C15N2-SEM |
Sulfamethoxazole (SMZ) | 磺胺甲基异 | 3.4 | 254 | 156*/147 | 50 | 23/22 | SDX-D3 |
1-Aminohydantoin (AHD) | 1-氨基-2-内酰脲 | 3.4 | 249 | 134*/104 | 60 | 18/33 | 13C3-AHD |
Sulfisoxazole (SIZ) | 磺胺二甲异 | 3.5 | 268 | 156*/113 | 45 | 20/23 | SDM-D6 |
3-Amino-2-oxazolidinone (AOZ) | 3-氨基- | 3.8 | 236 | 134*/104 | 61 | 18/33 | D4-AOZ |
Sulfaquinoxalin (SQX) | 磺胺喹 | 3.9 | 301 | 156*/108 | 55 | 24/37 | SDM-D6 |
Sulfadimethoxine (SDM) | 磺胺间二甲氧嘧啶 | 3.9 | 311 | 156*/108 | 70 | 31/35 | SDM-D6 |
Malachite green (MG) | 孔雀石绿 | 4.9 | 329 | 313*/208 | 101 | 53/46 | MG-D5 |
Leucomalachite green (LMG) | 隐色孔雀石绿 | 6.8 | 331 | 239*/315 | 76 | 45/32 | LMG-D6 |
Norfloxacin-D5(NOR-D5) | 诺氟沙星-D5 | 2.2 | 325 | 307 | 80 | 26 | |
Ciprofloxacin-D8 (CIP-D8) | 环丙沙星-D8 | 2.3 | 340 | 322 | 90 | 30 | |
D5-5-Morpholine-methyl-3-amino- | 5-甲基吗啉-3氨基- | 2.3 | 340 | 296 | 70 | 18 | |
2-oxazolidinone (D5-AMOZ) | |||||||
Enrofloxacin-D5(ENR-D5) | 恩诺沙星-D5 | 2.4 | 365 | 321 | 90 | 30 | |
Sulfadoxine-D3(SDX-D3) | 磺胺邻二甲氧嘧啶-D3 | 3.2 | 314 | 156 | 70 | 31 | |
13C15N2-Semicarbazide (13C15N2-SEM) | 13C15N2-氨基脲 | 3.3 | 212 | 168 | 57 | 15 | |
Chloramp henicol-D5 (CAP-D5) | 氯霉素-D5 | 3.3 | 326 | 157 | -75 | -22 | |
13C3-1-Aminohydantoin (13C3-AHD) | 13C3-1-氨基-2-内酰脲 | 3.4 | 252 | 134 | 61 | 18 | |
D4-3-Amino-2-oxazolidinone (D4-AOZ) | D4-3-氨基- | 3.8 | 240 | 134 | 68 | 20 | |
Sulfadimethoxine-D6(SDM-D6) | 磺胺间二甲氧嘧啶-D6 | 3.9 | 317 | 156 | 70 | 31 | |
Malachite green-D5 (MG-D5) | 孔雀石绿-D5 | 4.9 | 334 | 318 | 66 | 54 | |
Leucomalachite green-D6 (LMG-D6) | 隐色孔雀石绿-D6 | 6.7 | 337 | 321 | 66 | 32 |
Fig. 1 Total ion current chromatograms of the 28 veterinary drugs in MRM mode a. sulfonamides, quinolones, malachite green, leucomalachite green and nitrofuran metabolites; b. chloramphenicols.
Level | Factors | ||
Extraction reagent (A) | V(dipotassium phosphate solution) (B)/mL | Extraction times (C) | |
1 | ethyl acetate | 0 | 1 |
2 | acetonitrile | 13 | 2 |
3 | ethyl acetate-acetonitrile | 26 | 3 |
(1:1, v/v) |
Table 2 Orthogonal experiment conditions
Level | Factors | ||
Extraction reagent (A) | V(dipotassium phosphate solution) (B)/mL | Extraction times (C) | |
1 | ethyl acetate | 0 | 1 |
2 | acetonitrile | 13 | 2 |
3 | ethyl acetate-acetonitrile | 26 | 3 |
(1:1, v/v) |
Compound | Linear range/(μg/L) | Linear equation | r | LOD/(μg/kg) | LOQ/(μg/kg) |
y: peak area ratio of analyte to the internal standard; x: mass concentration of analyte, μg/L. | |||||
SD | 1.0-300 | y=0.0268x+0.0193 | 0.9990 | 0.7 | 2.3 |
ST | 1.0-300 | y=0.0282x+0.0520 | 0.9994 | 0.7 | 2.3 |
NOR | 1.0-300 | y=0.0139x+0.0108 | 0.9990 | 0.7 | 2.3 |
FLE | 1.0-300 | y=0.0929x+0.0735 | 0.9993 | 0.6 | 2.0 |
OFL | 1.0-300 | y=0.1100x+0.1280 | 0.9989 | 0.5 | 1.7 |
CIP | 1.0-300 | y=0.0206x+0.0365 | 0.9958 | 0.5 | 1.7 |
AMOZ | 0.5-80 | y=0.0377x-0.0050 | 0.9991 | 0.2 | 0.7 |
SMR | 1.0-300 | y=0.0309x+0.0013 | 0.9985 | 0.6 | 2.0 |
PEF | 1.0-300 | y=0.1230x-0.0263 | 0.9991 | 0.8 | 2.7 |
LOM | 1.0-300 | y=0.0500x+0.1230 | 0.9992 | 0.7 | 2.3 |
TAP | 0.2-80 | y=0.1830x+0.0012 | 0.9994 | 0.2 | 0.7 |
ENR | 1.0-300 | y=0.0678x+0.0761 | 0.9990 | 0.6 | 2.0 |
SMT | 1.0-300 | y=0.0251x+0.0258 | 0.9992 | 0.6 | 2.0 |
SMTZ | 1.0-300 | y=0.0141x+0.0416 | 0.9993 | 0.8 | 2.7 |
FF | 0.2-80 | y=0.4480x+0.0001 | 0.9992 | 0.2 | 0.7 |
SMM | 1.0-300 | y=0.0030x+0.0489 | 0.9989 | 0.7 | 2.3 |
SCP | 1.0-300 | y=0.0260x+0.0348 | 0.9989 | 0.7 | 2.3 |
CAP | 0.2-40 | y=0.0468x+0.0011 | 0.9991 | 0.1 | 0.3 |
SDX | 1.0-300 | y=0.0712x+0.1080 | 0.9984 | 0.5 | 1.7 |
SEM | 0.5-80 | y=0.0429x-0.0025 | 0.9991 | 0.2 | 0.7 |
SMZ | 1.0-300 | y=0.0301x+0.0753 | 0.9987 | 0.6 | 2.0 |
AHD | 0.5-80 | y=0.0336x-0.0046 | 0.9989 | 0.2 | 0.7 |
SIZ | 1.0-300 | y=0.0678x+0.0146 | 0.9994 | 0.8 | 2.7 |
AOZ | 0.5-80 | y=0.0350x-0.0042 | 0.9993 | 0.2 | 0.7 |
SQX | 1.0-300 | y=0.0821x+0.1111 | 0.9994 | 0.7 | 2.3 |
SDM | 1.0-300 | y=0.1530x+0.2700 | 0.9984 | 0.6 | 2.0 |
MG | 0.5-100 | y=0.0552x-0.0217 | 0.9998 | 0.1 | 0.3 |
LMG | 0.5-100 | y=1.3900x-5.5600 | 0.9994 | 0.2 | 0.7 |
Table 3 Linear ranges, linear equations, correlation coefficients (r), LODs and LOQs of the 28 veterinary drugs
Compound | Linear range/(μg/L) | Linear equation | r | LOD/(μg/kg) | LOQ/(μg/kg) |
y: peak area ratio of analyte to the internal standard; x: mass concentration of analyte, μg/L. | |||||
SD | 1.0-300 | y=0.0268x+0.0193 | 0.9990 | 0.7 | 2.3 |
ST | 1.0-300 | y=0.0282x+0.0520 | 0.9994 | 0.7 | 2.3 |
NOR | 1.0-300 | y=0.0139x+0.0108 | 0.9990 | 0.7 | 2.3 |
FLE | 1.0-300 | y=0.0929x+0.0735 | 0.9993 | 0.6 | 2.0 |
OFL | 1.0-300 | y=0.1100x+0.1280 | 0.9989 | 0.5 | 1.7 |
CIP | 1.0-300 | y=0.0206x+0.0365 | 0.9958 | 0.5 | 1.7 |
AMOZ | 0.5-80 | y=0.0377x-0.0050 | 0.9991 | 0.2 | 0.7 |
SMR | 1.0-300 | y=0.0309x+0.0013 | 0.9985 | 0.6 | 2.0 |
PEF | 1.0-300 | y=0.1230x-0.0263 | 0.9991 | 0.8 | 2.7 |
LOM | 1.0-300 | y=0.0500x+0.1230 | 0.9992 | 0.7 | 2.3 |
TAP | 0.2-80 | y=0.1830x+0.0012 | 0.9994 | 0.2 | 0.7 |
ENR | 1.0-300 | y=0.0678x+0.0761 | 0.9990 | 0.6 | 2.0 |
SMT | 1.0-300 | y=0.0251x+0.0258 | 0.9992 | 0.6 | 2.0 |
SMTZ | 1.0-300 | y=0.0141x+0.0416 | 0.9993 | 0.8 | 2.7 |
FF | 0.2-80 | y=0.4480x+0.0001 | 0.9992 | 0.2 | 0.7 |
SMM | 1.0-300 | y=0.0030x+0.0489 | 0.9989 | 0.7 | 2.3 |
SCP | 1.0-300 | y=0.0260x+0.0348 | 0.9989 | 0.7 | 2.3 |
CAP | 0.2-40 | y=0.0468x+0.0011 | 0.9991 | 0.1 | 0.3 |
SDX | 1.0-300 | y=0.0712x+0.1080 | 0.9984 | 0.5 | 1.7 |
SEM | 0.5-80 | y=0.0429x-0.0025 | 0.9991 | 0.2 | 0.7 |
SMZ | 1.0-300 | y=0.0301x+0.0753 | 0.9987 | 0.6 | 2.0 |
AHD | 0.5-80 | y=0.0336x-0.0046 | 0.9989 | 0.2 | 0.7 |
SIZ | 1.0-300 | y=0.0678x+0.0146 | 0.9994 | 0.8 | 2.7 |
AOZ | 0.5-80 | y=0.0350x-0.0042 | 0.9993 | 0.2 | 0.7 |
SQX | 1.0-300 | y=0.0821x+0.1111 | 0.9994 | 0.7 | 2.3 |
SDM | 1.0-300 | y=0.1530x+0.2700 | 0.9984 | 0.6 | 2.0 |
MG | 0.5-100 | y=0.0552x-0.0217 | 0.9998 | 0.1 | 0.3 |
LMG | 0.5-100 | y=1.3900x-5.5600 | 0.9994 | 0.2 | 0.7 |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||